Cargando…
A retrospective cohort study on European Reference Network for Rare Vascular Diseases 5 outcome measures for Hereditary Haemorrhagic Telangiectasia in Denmark
BACKGROUND: Hereditary Haemorrhagic Telangiectasia (HHT) is an autosomal dominant disorder characterized by several clinical symptoms including epistaxis, arteriovenous malformations (AVM), and telangiectasia. In 2018, European Reference Network for Rare Vascular Diseases (VASCERN) recommended five...
Autores principales: | Hvelplund, Troels, Lange, Bibi, Bird, Susanne Djernes, Korsholm, Malene, Kjeldsen, Anette Drøhse |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734368/ https://www.ncbi.nlm.nih.gov/pubmed/34991676 http://dx.doi.org/10.1186/s13023-021-02160-1 |
Ejemplares similares
-
The bleeding diathesis in patients with hereditary haemorrhagic telangiectasia is not due to impaired platelet function
por: Lyster, Anne Lørup, et al.
Publicado: (2023) -
European Reference Network For Rare Vascular Diseases (VASCERN) Outcome Measures For Hereditary Haemorrhagic Telangiectasia (HHT)
por: Shovlin, Claire L., et al.
Publicado: (2018) -
Skin and mucosal telangiectatic lesions in hereditary hemorrhagic telangiectasia patients
por: Hyldahl, Stefanie J., et al.
Publicado: (2022) -
European Reference Network for Rare Vascular Diseases (VASCERN) position statement on cerebral screening in adults and children with hereditary haemorrhagic telangiectasia (HHT)
por: Eker, Omer F., et al.
Publicado: (2020) -
Long Non-Coding RNA Expression Profiles in Hereditary Haemorrhagic Telangiectasia
por: Tørring, Pernille M., et al.
Publicado: (2014)